What does this research mean for the field?

Nanoparticle-based strategies for signal amplification have significantly enhanced the analytical performance of lateral flow immunoassays, improving detection limits from the nanomolar range to picomolar and femtomolar levels. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to critically assess how nanoparticle strategies improve signal amplification and performance in lateral flow immunoassays (LFIAs).

February 25, 2026Nano TrendsOpen Access

Nano-biosensing Meets Point-of-Care: Critical Review of Nanoparticle-Based Signal Amplification in Lateral Flow Assays

View Full Paper

Ask AI

Bookmark

Authors

DKDinesh KumarNational Institute of Food Technology Entrepreneurship and Management AJAyushi JainNational Institute of Food Technology Entrepreneurship and Management HOHarinder Singh OberoiIndian Institute of Horticultural Research

Discussion

Member takes

Implication

This review evaluates nanoparticle-based signal amplification in lateral flow assays, indicating implications for point-of-care diagnostics.

Key Points

The aim is to critically assess how nanoparticle strategies improve signal amplification and performance in lateral flow immunoassays (LFIAs).
Reviewed existing literature on LFIA technologies and components
Evaluated various detection labels and their impact on sensitivity
Discussed optimization strategies for sample and conjugate pads
Analyzed performance metrics including detection limits and multiplexing capabilities
Explored challenges in assay accuracy and interference
Detection limits improved to picomolar and femtomolar levels using nanoparticle strategies
Multiplexing capabilities allow detection of 3–10 analytes simultaneously
Significant enhancements in sensitivity through optimized fluid dynamics and protein stabilization
Advanced labeling techniques achieve detection limits around 0.1 ng/mL
Integration of computational modeling enhances calibration accuracy and quantitative analysis.

Cite This Study

Kumar et al. (2026) studied this question.

synapsesocial.com/papers/699e90eff5123be5ed04e1e5 https://doi.org/10.1016/j.nwnano.2026.100194

View Full Paper

Ask AI

Bookmark

Implication

This review evaluates nanoparticle-based signal amplification in lateral flow assays, indicating implications for point-of-care diagnostics.

Nano-biosensing Meets Point-of-Care: Critical Review of Nanoparticle-Based Signal Amplification in Lateral Flow Assays

Discussion

Member takes

Implication

Key Points

Cite This Study

Nano-biosensing Meets Point-of-Care: Critical Review of Nanoparticle-Based Signal Amplification in Lateral Flow Assays

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider